Surmodics | SRDX - Валовая прибыль





Валовая прибыль Изменить Дата
Abbott USD 6.54B 625M 2025-12
Align Technology USD 683.59M 44.39M 2025-12
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 256.47M 228.7M 2025-09
Artivion USD 73.14M 1.25M 2025-12
Baxter International USD 577M 373M 2025-12
Boston Scientific USD 3.68B 136M 2025-12
EDAP TMS EUR 5.97M 850K 2025-09
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
J&J USD 16.6B 118M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Mesa Laboratories USD 39.75M 4.3M 2024-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Option Care Health USD 282.9M 10M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD 20.08M 31.62M 2025-06
Trinity Biotech USD 6.47M 1.59M 2025-09